Exhibit 10.1

 

AMENDMENT NO. 3 TO TESTING AND SERVICES AGREEMENT

﻿

THIS AMENDMENT NO. 3 TO TESTING AND SERVICES AGREEMENT (this “Amendment”) is
made and entered into as of the date on which both parties have executed this
Amendment (the “Amendment Effective Date”) by and between Quest Diagnostics
Incorporated, a Delaware corporation (“Quest Diagnostics”) on the one hand, and
Vermillion, Inc., a Delaware corporation and ASPiRA Labs, a Delaware corporation
and wholly owned subsidiary of Vermillion, Inc. (collectively “Vermillion”) on
the other hand, with respect to that certain Testing and Services Agreement
dated as of March 11, 2015, and that certain Amendment No. 1 to Testing and
Services Agreement dated as of April 10, 2015 and that certain Amendment No. 2
to Testing and Services Agreement dated as of March 11, 2017 (together, the
“TSA”).  Capitalized terms used and not otherwise deﬁned herein are used with
the meanings attributed to them in the TSA.  All references to section numbers
refer to section numbers in the TSA.

﻿

WITNESSETH:

NOW THEREFORE, in consideration of the premises and the mutual agreements
contained herein, the parties agree the TSA is hereby amended as follows:

1.

Section 5.3 of the TSA is hereby deleted in its entirety and the following new
Section 5.3 is substituted in its place:

﻿

5.3This agreement shall terminate in four years from the Effective Date and
shall renew for an additional one-year period thereafter by the written
agreement of the Parties at least 60 days prior to such renewal date. 

﻿

2.

The following new Section 8.9 is inserted into the TSA, effective as of the
Amendment Date: November 1, 2017

8.9Quest Diagnostics will assign a full-time project manager to Vermillion’s
account to provide certain services to resolve issues arising from the
performance of Services and with respect to Specimens sourced to Quest
Diagnostics’ testing lab through its Patient Service Centers and its In-office
Phlebotomists (IOPs).  The fee for such project manager shall be $150,000 (One
hundred fifty thousand dollars) per year (the “Annual Service Fee”).  Vermillion
shall pay to Quest the Annual Service Fee in 4 (four) equal installments on a
quarterly basis throughout the Term of this Agreement at the time payments are
made for blood draw fees.  Project manager will be assigned and meet with an
assigned Vermillion point of contact to resolve any issues with respect to
Services.  

--------------------------------------------------------------------------------

 

Any additional work to be covered by the Annual Service Fee must be approved by
in writing by both Parties.

﻿

3.

Except as expressly modified by this Amendment, all terms and conditions of the
TSA remain in full force and effect.

﻿

﻿

[Intentionally left blank]

﻿

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, the parties intending to be legally bound, have set their
hands the date and year first above written.

﻿

 

QUEST DIAGNOSTICS INCORPORATED

VERMlLLION, INC.

By: /s/ Kristie Dolan

By: /s/ Fred Ferrara

Print Name: Kristie Dolan

Print Name: Fred Ferrara

Title: GM Oncology

Title: COO

Date: 1/24/18

Date: 3/1/2018

﻿

 

ASPIRA LABS, INC.

 

By: /s/ Fred Ferrara

 

Print Name: Fred Ferrara

 

Title: COO

 

Date: 3/1/2018

 

﻿

﻿

--------------------------------------------------------------------------------